Fabrication, characterization and in vitro release of paclitaxel (Taxol®) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers

Journal of Controlled Release

Volumn 76, Issue 3, 2001, Pages 239-254

  Mu, L ^a   Feng, S S ^a,b  

^a INSTITUTE OF MATERIALS RESEARCH AND ENGINEERING   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Anticancer agent; Emulsifiers; Microspheres; Paclitaxel; Spray dry

Indexed keywords

CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; EMULSIFYING AGENT; GELATIN; LIPID; MICROSPHERE; PACLITAXEL; POLYGLACTIN; POLYVINYL ALCOHOL;

ARTICLE; ATOMIC FORCE MICROSCOPY; BIODEGRADATION; CONTROLLED DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; ENCAPSULATION; KINETICS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUSTAINED RELEASE PREPARATION; ZETA POTENTIAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; DRUG CARRIERS; DRUG COMPOUNDING; EMULSIONS; LACTIC ACID; LIPIDS; MICROSPHERES; PACLITAXEL; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS;

EID: 0035914220     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(01)00440-0     Document Type: Article

References (41)

1. Mechanism of action of taxol
2. Taxanes. A new class of antitumour agents
3. FDA approves Taxol to treat early-stage breast cancer. Drug improves a patient's prognosis from good to 'great'
4. Solid-state characterization of paclitaxel
5. Measurement of Cremophor EL following taxol: Plasma levels sufficient to reverse drug exclusion mediated by the multidrug-resistant phenotype
6. Is cremophor, solvent for paclitaxel, cytotoxic?
7. Pharmacology and toxicology of Cremophor EL diluent
8. Interaction of Cremophor-EL with human plasma
9. Effects of cyclosporin and cremophor on working rat heart and incidence of myocardial lipid peroxidation
10. Acute effects of cyclosporine and Cremophor EL on endothelial function and vascular smooth-muscle in the isolated rat-heart
11. Compatibility of docetaxel and paclitaxel in intravenous solutions with polyvinyl chloride infusion materials
12. In vitro and in vivo antitumoral activity of free and encapsulated taxol
13. Paclitaxel-liposomes for intracavitary therapy of intraperitoneal P388 leukemia
14. Antitumor activity of paclitaxel-2′-glycinate conjugated to poly(ethylene glycol): A water-soluble prodrug
15. Synthesis and β-lactamase-mediated activation of cephalosporin-taxol prodrug
16. Preparation and characterization and properties in vitro and in vivo of a paclitaxel-albumin conjugates
17. Pharmaceutical and physical properties of paclitaxel (taxol) complexes with cyclodextrins
18. A new parenteral emulsion for administration of taxol
19. Transcatheter arterial chemoembolization therapy for hepatocellular carcinoma using polylactic acid microspheres containing aclarubicin hydrochloride
20. Controlled delivery of taxol from microspheres composed of a blend acetate copolymer and poly D,L-lactic acid
21. Preparation and characterization of poly(lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent
22. In vitro and in vivo evaluation of taxol release from poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate and degradation of the microspheres
23. Physical chemical properties of indomethacin and related compounds co-spray-dried with polyvinylpyrrolidone
24. Spray-drying as a preparation method of microparticulate drug delivery systems: An overview
25. Preparation of microspheres for intra-articular administration
26. Chitosan microspheres prepared by spray drying
27. Optimization of preparative conditions for poly-DL-lactide-polyethylene glycol microspheres with entrapped vibrio cholera antigens
28. Preparation of biodegradable poly(±)lactide microparticles using a spray-drying technique
29. Technological considerations related to the up-scaling of protein microencapsulation by spray-drying
30. Spray dried polylactide microsphere preparation: Influence of the technological parameters
31. Quality improvement of spray-dried protein loaded D,L-PLA microspheres by appropriate polymer solvent selection
32. Thermoanalysis of microspheres
33. Thermal analysis of spray dried products
34. The colloidal properties of surfactant-free biodegradable nanospheres from poly (β-malic acid-cobenzyl malate)s and poly(lactic acid-co-glycolide)
35. New methods of drug delivery
36. Parental depot-systems on the basis of biodegradable polyesters
37. The preparation and characterization of microspheres containing the anti-inflammatory agents indomethacin, ibuprofen and ketoprofen
38. Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers